跳至主要内容
临床试验/NCT06704243
NCT06704243已完成不适用

Peer Support Group for AYA Allogeneic Stem Cell Transplant Recipients

University Health Network, Toronto1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2024年5月24日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
13
试验地点
1
主要终点
Feasibility of Intervention Measure (FIM)

研究概览

简要总结

Allogeneic Haemopoietic Stem Cell Transplant (Allo-HSCT) is a potentially curative option for patients with both malignant and non-malignant hematological disorders. There appears to be unique experiences that adolescents and young adults (AYA) face when undergoing transplant. There is literature to suggest that peer support for young adults is associated with improvements in mental health including greater happiness, self-esteem and effective coping, as well as reductions in depression, loneliness and anxiety.

Our primary objective is to determine the feasibility and acceptability of an AYA peer support program for patients undergoing Allo-HSCT. Our secondary objective is to explore the impact of the AYA peer support program on sense of support/connectivity, anxiety, and depression.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 39 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • 18-39 years of age
  • >3 months post Allo-HSCT
  • any malignant /non-malignant indication for Allo-HSCT

排除标准

  • - Non-English speaking

研究组 & 干预措施

Peer Support

Experimental

The intervention will be a monthly online AYA peer support group (1 hour) that will run for six months via Microsoft Teams.

干预措施: Peer Support (Behavioral)

结局指标

主要结局

Feasibility of Intervention Measure (FIM)

时间窗: at 6 months

The Feasibility of Intervention Measure (FIM) revised to evaluated the AYA peer support program comprises 4-items regarding the respondent's perceptions of the feasibility of the intervention. Responses range from 1 (completely disagree) to 5 (completely agree). Scale value is computed by averaging responses and ranges from 1-5. Higher values indicate greater feasibility of the intervention.

Acceptability of Intervention Measure (AIM)

时间窗: at 6 months

The Acceptability of Intervention Measure (AIM) revised to evaluated the AYA peer support program comprises 4-items regarding the respondent's perceptions of the acceptability of the intervention. Responses range from 1 (completely disagree) to 5 (completely agree). Scale value is computed by averaging responses and ranges from 1-5. Higher values indicate greater acceptability of the intervention.

Intervention Appropriateness Measure (IAM)

时间窗: at 6 months

The Intervention Appropriate Measure (IAM) revised to evaluated the AYA peer support program comprises 4-items regarding the respondent's perceptions of the appropriateness of the intervention. Responses range from 1 (completely disagree) to 5 (completely agree). Scale value is computed by averaging responses and ranges from 1-5. Higher values indicate greater appropriateness of the intervention.

Post-intervention Qualitative interviews

时间窗: at 6 months

Post-intervention qualitative interviews with participants will also explore their perceptions of the feasibility and acceptability of the intervention, including suggestions for improvement of the intervention. These semi-structured interviews will also help explore participant's opinions related to program length, time, usefulness, and delivery.

Intervention usage

时间窗: at 6 months

Intervention usage (i.e. proportion of sessions attended by each participant) will be calculated based on attendance lists for each session collected by the session facilitators. Reasons for non-attendance or early drop-out from a session will be collected, but this is optional for participants.

次要结局

  • Social Connectedness(Baseline, 3 months, and 6 months)
  • Anxiety(Baseline, 3 months, and 6 months)
  • Depressive Symptoms(Baseline, 3 months, and 6 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Samantha Mayo

Clinician Investigator

University Health Network, Toronto

研究点 (1)

Loading locations...

相似试验

Peer Support Group for Adolescent and Young Adult... | 临床试验